# Brian A. Ference

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/brian-a-ference/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,775 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 52 |
| i10-index | 79 |
| Last Known Institution | University of Cambridge |
| OpenAlex ID | https://openalex.org/A5105286197 |
| Works | 137 |

## Researcher papers

- [2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-i-lipid/)
- [2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-lipid-modification/)
- [Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel](https://scholariq.org/papers/low-density-lipoproteins-cause-atherosclerotic-cardiovascular-disease-1-evidence/)
- [Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel](https://scholariq.org/papers/low-density-lipoproteins-cause-atherosclerotic-cardiovascular-disease/)
- [Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement](https://scholariq.org/papers/lipoprotein-a-in-atherosclerotic-cardiovascular-disease-and-aortic-stenosis-a/)
- [SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions](https://scholariq.org/papers/score2-op-risk-prediction-algorithms-estimating-incident-cardiovascular-event/)
- [2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias](https://scholariq.org/papers/2025-focused-update-of-the-2019-esc-eas-guidelines-for-the-management-of/)
- [SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe](https://scholariq.org/papers/score2-diabetes-10-year-cardiovascular-risk-estimation-in-type-2-diabetes-in/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)

## Researcher university

- [University of Cambridge](https://scholariq.org/institutions/university-of-cambridge/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.